In human monocytes activated through nine different immune pathways, CBD selectively suppressed two pro-inflammatory cytokines (IL-1β and IL-6) while leaving most other immune signals unaffected.
Immunologists, CBD researchers, inflammation biologists
CBD selectively suppressed IL-1β and IL-6 while leaving 11 other immune mediators unaffected
What the researchers found
CBD (0.5-10 μM) significantly suppressed IL-1β secretion across most toll-like receptor pathways and modulated IL-6 production, while 11 other immune mediators remained largely unaffected, revealing a highly selective anti-inflammatory profile.
Why it matters
The finding that CBD's anti-inflammatory effects are selective rather than broadly immunosuppressive helps explain why CBD may reduce inflammation without the widespread immune suppression seen with conventional anti-inflammatory drugs.
The numbers in context
CBD tested at 0.5-10 μM; 9 toll-like receptors tested; 13 immune mediators measured; significant suppression of IL-1β through most TLRs (except TLR3 and TLR8); significant modulation of IL-6 through most TLRs (except TLR1 and TLR3); 11 other mediators largely unaffected.
How the study worked
In vitro study treating human primary monocytes activated through each of nine toll-like receptors with CBD at multiple concentrations, measuring secretion of 13 immune mediators.
What this study cannot tell us
In vitro study may not reflect in vivo effects; CBD concentrations tested may not correspond to levels achievable through oral consumption; monocytes are only one component of the immune system.
How to read the evidence
In vitro study using human primary cells provides preliminary mechanistic evidence requiring clinical validation.
When this study was published
Published in 2021.
The bigger picture
As CBD products are widely consumed by the public, understanding exactly which immune pathways CBD affects in human cells provides essential foundational data for evaluating both therapeutic potential and safety concerns.
Questions still open
- Do these selective anti-inflammatory effects translate to measurable clinical benefits in people with inflammatory conditions? What CBD blood levels are needed to achieve the concentrations tested?
Common questions
Does CBD suppress the whole immune system?
Why do IL-1β and IL-6 matter?
Read the original research
Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes.
Toxicology, 464, 153016
Citation
Sermet, Sera; Li, Jinpeng; Bach, Anthony; Crawford, Robert B; Kaminski, Norbert E. (2021). Cannabidiol selectively modulates interleukin (IL)-1β and IL-6 production in toll-like receptor activated human peripheral blood monocytes.. Toxicology, 464, 153016. https://doi.org/10.1016/j.tox.2021.153016
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk